Marina Otten
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marina Otten has a total of 84 co-authors. Here are the top co-authors by number of shared publications:
- Matthias Augustin
Institut für Versorgungsforschung in der Dermatologie und bei Pflegeberufen (IVDP) Universitätsklinikum Hamburg‐Eppendorf (UKE) Hamburg Deutschland
16 shared publications - Patrick Reinders
Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany
10 shared publications - Alexander Zink
Department of Dermatology and Allergy, School of Medicine Technical University of Munich Munich Germany
5 shared publications - Anastasia Fleyder
Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
4 shared publications - Natalia Kirsten
CeDeF - Dermatologische Forschung und Ambulanzen, Institut für Versorgungsforschung in der Dermatologie und bei Pflegeberufen, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Deutschland
4 shared publications Matthias Augustin
Competenzzentrum für Versorgungsforschung in der Dermatologie (CVderm) Institut für Versorgungsforschung in der Dermatologie und bei Pflegeberufen (IVDP) Universitätsklinikum Hamburg‐Eppendorf (UKE) Hamburg
3 shared publications
Latest Publications
- Open Access
- 5 October 2026
- Published by Wiley in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
- Vol. 24 (10) , 1435-1440
Digitale Gesundheitsanwendungen, Telemedizin und Large Language Models in der Dermatologie: Ergebnisse einer deutschlandweiten Befragung
Zusammenfassung: Hintergrund: Digitale Technologien bieten Chancen für die dermatologische Versorgung, doch fehlen systematische Daten zur Nutzung und Akzeptanz, insbesondere zu digitalen Gesundheitsanwendungen (DiGA) und Large Language Models (LLMs). Patienten und Methodik: Von November 2024 bis Januar 2025 wurde eine anonyme Online‐Befragung unter Dermatolog*innen im Rahmen von Fortbildungen durchgeführt. Erfasst wurden Nutzung und Einstellungen zu Telemedizin, DiGA und LLMs sowie Kompetenzeinschätzungen und Fortbildungsbedarf. Ergebnisse: 100 Dermatologen nahmen teil (64% weiblich, Durchschnittsalter 40,6 Jahre). 58% gaben an, derzeit keine telemedizinischen Leistungen anzubieten; lediglich 5 % nutzten regelmäßig Videosprechstunden. 21% hatten bereits DiGA verordnet, wobei die Mehrheit (78%) die Verantwortung dafür bei Allgemeinärzt*innen sah. 96% der Dermatolog*innen waren der Ansicht, dass DiGA die medizinische Versorgung verbessern können. Als Hauptbarrieren wurden mangelndes Wissen (76%), fehlende Zeit (74%) sowie unzureichende Vergütung und ein komplexer Verschreibungsprozess (je 43%) genannt. 45% der Befragten hatten LLMs im beruflichen Kontext genutzt. 76% bewerteten die Auswirkungen der Digitalisierung auf die Patientenversorgung als positiv und 80% äußerten den Wunsch nach Fortbildungsangeboten zum Einsatz digitaler Technologien im ärztlichen Alltag. Schlussfolgerung: Die Digitalisierung und insbesondere DiGA werden von Dermatologen überwiegend positiv wahrgenommen, digitale Angebote werden jedoch bislang kaum genutzt. Ein gezielter Wissensausbau und konkrete Fortbildungsangebote könnten die Implementierung digitaler Technologien im dermatologischen Alltag wesentlich fördern.
- 5 October 2026
- Published by Wiley in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
- Vol. 24 (10) , 1435-1440
Open AccessDigitale Gesundheitsanwendungen, Telemedizin und Large Language Models in der Dermatologie: Ergebnisse einer deutschlandweiten Befragung
Zusammenfassung: Hintergrund: Digitale Technologien bieten Chancen für die dermatologische Versorgung, doch fehlen systematische Daten zur Nutzung und Akzeptanz, insbesondere zu digitalen Gesundheitsanwendungen (DiGA) und Large Language Models (LLMs). Patienten und Methodik: Von November 2024 bis Januar 2025 wurde eine anonyme Online‐Befragung unter Dermatolog*innen im Rahmen von Fortbildungen durchgeführt. Erfasst wurden Nutzung und Einstellungen zu Telemedizin, DiGA und LLMs sowie Kompetenzeinschätzungen und Fortbildungsbedarf. Ergebnisse: 100 Dermatologen nahmen teil (64% weiblich, Durchschnittsalter 40,6 Jahre). 58% gaben an, derzeit keine telemedizinischen Leistungen anzubieten; lediglich 5 % nutzten regelmäßig Videosprechstunden. 21% hatten bereits DiGA verordnet, wobei die Mehrheit (78%) die Verantwortung dafür bei Allgemeinärzt*innen sah. 96% der Dermatolog*innen waren der Ansicht, dass DiGA die medizinische Versorgung verbessern können. Als Hauptbarrieren wurden mangelndes Wissen (76%), fehlende Zeit (74%) sowie unzureichende Vergütung und ein komplexer Verschreibungsprozess (je 43%) genannt. 45% der Befragten hatten LLMs im beruflichen Kontext genutzt. 76% bewerteten die Auswirkungen der Digitalisierung auf die Patientenversorgung als positiv und 80% äußerten den Wunsch nach Fortbildungsangeboten zum Einsatz digitaler Technologien im ärztlichen Alltag. Schlussfolgerung: Die Digitalisierung und insbesondere DiGA werden von Dermatologen überwiegend positiv wahrgenommen, digitale Angebote werden jedoch bislang kaum genutzt. Ein gezielter Wissensausbau und konkrete Fortbildungsangebote könnten die Implementierung digitaler Technologien im dermatologischen Alltag wesentlich fördern.
- Open Access
- 8 September 2026
- Published by Wiley in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
- Vol. 24 (9) , 1264-1276
Einstellungen dermatologischer Patienten gegenüber digitalen Gesundheitsinterventionen: Eine Querschnittsbefragung und Clusteranalyse
Zusammenfassung: Hintergrund und Ziele: Ziel dieser Studie war es, die Akzeptanz digitaler Gesundheitsinterventionen (DHI) bei Patienten in der Dermatologie zu bewerten und Patientengruppen zu identifizieren. Patienten und Methoden: Eine quantitative Querschnittsbefragung zur Akzeptanz und (künftigen) Nutzung von DHI unter Patienten mit chronischen Hauterkrankungen wurde durchgeführt. Mittels explorativer Faktorenanalyse (EFA) wurden Faktoren identifiziert und die Patienten anhand eines zweistufigen Clustering‐Ansatzes in Gruppen eingeteilt. Ergebnisse: Die EFA verwendete Daten von 344 Patienten (M 52,5 Jahre, SD 14,8; 74,0 % weiblich) und ergab vier Faktoren: „Akzeptanz/Vertrauen“, „Digitale Gesundheitskompetenzen“, „Unsicherheiten“ und „Positive Auswirkungen“. Die Clusteranalyse ergab vier Gruppen: „Digitale Skeptiker“ (n = 49, 15,6 %), „Vorsichtige Anwender“ (n = 106, 33,7 %), „Digitale Enthusiasten“ (n = 98, 31,1 %) und „Anwender, unsicher über die Auswirkungen“ (n = 62, 18,0 %). Die „Digitalen Enthusiasten“ waren deutlich jünger. Die Nutzung und Akzeptanz variierten zwischen den Clustern, wobei die „Enthusiasten“ und die „Anwender, unsicher über die Auswirkungen“ die höchsten Werte aufwiesen. Insgesamt nutzten nur wenige Patienten DHI, darunter Store‐and‐Forward‐Teledermatologie (2,0–7,0 %) oder elektronische Patientenakten (6,4–19,4 %). Schlussfolgerungen: Patientengruppen mit unterschiedlichen Einstellungen gegenüber DHI wurden identifiziert. Trotz einer allgemeinen Bereitschaft zur Einführung von DHI bleibt die tatsächliche Nutzung gering. Systemische Barrieren, wie Verfügbarkeit und digitale Kompetenzen, müssen angegangen werden.
- 8 September 2026
- Published by Wiley in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
- Vol. 24 (9) , 1264-1276
Open AccessEinstellungen dermatologischer Patienten gegenüber digitalen Gesundheitsinterventionen: Eine Querschnittsbefragung und Clusteranalyse
Zusammenfassung: Hintergrund und Ziele: Ziel dieser Studie war es, die Akzeptanz digitaler Gesundheitsinterventionen (DHI) bei Patienten in der Dermatologie zu bewerten und Patientengruppen zu identifizieren. Patienten und Methoden: Eine quantitative Querschnittsbefragung zur Akzeptanz und (künftigen) Nutzung von DHI unter Patienten mit chronischen Hauterkrankungen wurde durchgeführt. Mittels explorativer Faktorenanalyse (EFA) wurden Faktoren identifiziert und die Patienten anhand eines zweistufigen Clustering‐Ansatzes in Gruppen eingeteilt. Ergebnisse: Die EFA verwendete Daten von 344 Patienten (M 52,5 Jahre, SD 14,8; 74,0 % weiblich) und ergab vier Faktoren: „Akzeptanz/Vertrauen“, „Digitale Gesundheitskompetenzen“, „Unsicherheiten“ und „Positive Auswirkungen“. Die Clusteranalyse ergab vier Gruppen: „Digitale Skeptiker“ (n = 49, 15,6 %), „Vorsichtige Anwender“ (n = 106, 33,7 %), „Digitale Enthusiasten“ (n = 98, 31,1 %) und „Anwender, unsicher über die Auswirkungen“ (n = 62, 18,0 %). Die „Digitalen Enthusiasten“ waren deutlich jünger. Die Nutzung und Akzeptanz variierten zwischen den Clustern, wobei die „Enthusiasten“ und die „Anwender, unsicher über die Auswirkungen“ die höchsten Werte aufwiesen. Insgesamt nutzten nur wenige Patienten DHI, darunter Store‐and‐Forward‐Teledermatologie (2,0–7,0 %) oder elektronische Patientenakten (6,4–19,4 %). Schlussfolgerungen: Patientengruppen mit unterschiedlichen Einstellungen gegenüber DHI wurden identifiziert. Trotz einer allgemeinen Bereitschaft zur Einführung von DHI bleibt die tatsächliche Nutzung gering. Systemische Barrieren, wie Verfügbarkeit und digitale Kompetenzen, müssen angegangen werden.
- Open Access
- 16 April 2026
- Published by Wiley in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
- Vol. 24 (9)
Attitudes of dermatological patients towards digital health interventions: a cross‐sectional survey and cluster analysis
Summary: Background: This study aimed to assess the acceptance of Germany's adoption of digital health interventions (DHI) among dermatology patientsand to identify patient clusters. Patients and Methods: A cross‐sectional, quantitative survey on acceptability and (future) usage of DHIs was conducted among patients with chronic dermatological conditions. Exploratory Factor Analysis (EFA) identified key constructs and patients were grouped using a two‐step clustering approach. Results: The EFA was conducted using data from 344 patients (mean age 52.5 years, SD 14.8; 74.0 % female) and identified four factors: “Acceptability of DHIs and Trust,” “Patients’ Digital Health Competencies,” “Digital Health Insecurities,” and “Positive Impact of DHIs.” Cluster analysis resulted in four groups: “Digital Sceptics” (n = 49, 15.6 %), “Cautious Adopters” (n = 106, 33.7 %), “Digital Enthusiasts” (n = 98, 31.1 %), “Adopters Unsure About Impact” (n = 62, 18.0 %). “Digital Enthusiasts” were significantly younger. Usage and acceptability varied among clusters, with “Digital Enthusiasts” and “Adopters Unsure About Impact” showing the highest rates. Overall, few patients used DHIs, including store‐and‐forward teledermatology (2.0 %–7.0 %) or electronic patient records (6.4 %–19.4 %). Conclusions: Patient clusters with varying attitudes towards DHIs were identified. Despite a general willingness to adopt DHIs, actual usage remains low. Systemic barriers such as availability and digital competencies need to be addressed.
- 16 April 2026
- Published by Wiley in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
- Vol. 24 (9)
Open AccessAttitudes of dermatological patients towards digital health interventions: a cross‐sectional survey and cluster analysis
Summary: Background: This study aimed to assess the acceptance of Germany's adoption of digital health interventions (DHI) among dermatology patientsand to identify patient clusters. Patients and Methods: A cross‐sectional, quantitative survey on acceptability and (future) usage of DHIs was conducted among patients with chronic dermatological conditions. Exploratory Factor Analysis (EFA) identified key constructs and patients were grouped using a two‐step clustering approach. Results: The EFA was conducted using data from 344 patients (mean age 52.5 years, SD 14.8; 74.0 % female) and identified four factors: “Acceptability of DHIs and Trust,” “Patients’ Digital Health Competencies,” “Digital Health Insecurities,” and “Positive Impact of DHIs.” Cluster analysis resulted in four groups: “Digital Sceptics” (n = 49, 15.6 %), “Cautious Adopters” (n = 106, 33.7 %), “Digital Enthusiasts” (n = 98, 31.1 %), “Adopters Unsure About Impact” (n = 62, 18.0 %). “Digital Enthusiasts” were significantly younger. Usage and acceptability varied among clusters, with “Digital Enthusiasts” and “Adopters Unsure About Impact” showing the highest rates. Overall, few patients used DHIs, including store‐and‐forward teledermatology (2.0 %–7.0 %) or electronic patient records (6.4 %–19.4 %). Conclusions: Patient clusters with varying attitudes towards DHIs were identified. Despite a general willingness to adopt DHIs, actual usage remains low. Systemic barriers such as availability and digital competencies need to be addressed.
- Open Access
- 19 January 2026
- Published by Wiley in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
- Vol. 24 (10)
Digital health applications, telemedicine and large language models in dermatology: results of a Germany‐wide survey
Background : Digital technologies offer opportunities for dermatological care, but there is a lack of systematic data on their use and acceptance, particularly with regard to digital health applications (DiGA) and large language models (LLMs). Patients and Methods : From November 2024 to January 2025, an anonymous online survey was conducted among German dermatologists as part of continuing education courses. The survey covered the use of and attitudes towards telemedicine, DiGA and LLMs, as well as competence assessments and education needs. Results : 100 dermatologists participated (64% female, average age 40.6 years). 58% stated that they did not currently offer telemedicine services; only 5% regularly used video consultations. 21% had already prescribed DiGA, with the majority (78%) seeing this as the responsibility of general practitioners. 96% of dermatologists believed that DiGA could improve medical care. The main barriers cited were lack of knowledge (76%), lack of time (74%), insufficient remuneration and a complex prescription process (43% each). 45% of respondents had used LLMs in a professional context. 76% rated the impact of digitalization on patient care as positive, and 80% expressed a desire for training opportunities on the use of digital technologies in everyday medical practice. Conclusion : Digitalization and, in particular, DiGA are viewed positively by most dermatologists, but digital services are hardly used at present. Targeted knowledge expansion and specific training opportunities could significantly promote the implementation of digital technologies in everyday dermatological practice.
- 19 January 2026
- Published by Wiley in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
- Vol. 24 (10)
Open AccessDigital health applications, telemedicine and large language models in dermatology: results of a Germany‐wide survey
Background : Digital technologies offer opportunities for dermatological care, but there is a lack of systematic data on their use and acceptance, particularly with regard to digital health applications (DiGA) and large language models (LLMs). Patients and Methods : From November 2024 to January 2025, an anonymous online survey was conducted among German dermatologists as part of continuing education courses. The survey covered the use of and attitudes towards telemedicine, DiGA and LLMs, as well as competence assessments and education needs. Results : 100 dermatologists participated (64% female, average age 40.6 years). 58% stated that they did not currently offer telemedicine services; only 5% regularly used video consultations. 21% had already prescribed DiGA, with the majority (78%) seeing this as the responsibility of general practitioners. 96% of dermatologists believed that DiGA could improve medical care. The main barriers cited were lack of knowledge (76%), lack of time (74%), insufficient remuneration and a complex prescription process (43% each). 45% of respondents had used LLMs in a professional context. 76% rated the impact of digitalization on patient care as positive, and 80% expressed a desire for training opportunities on the use of digital technologies in everyday medical practice. Conclusion : Digitalization and, in particular, DiGA are viewed positively by most dermatologists, but digital services are hardly used at present. Targeted knowledge expansion and specific training opportunities could significantly promote the implementation of digital technologies in everyday dermatological practice.
- Open Access
- 28 August 2025
- Published by SAGE Publications in Therapeutic Advances in Musculoskeletal Disease
- Vol. 17
Orthopaedic physicians’ awareness, diagnostic challenges and referral barriers in axial spondyloarthritis: insights from a nationwide survey in Germany
Background: Axial spondyloarthritis (axSpA) is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, potentially leading to pain, stiffness and disability. Despite diagnostic advances, delays persist. Orthopaedic physicians, often the first specialists consulted for back pain, play a crucial role in early detection and referral to rheumatologists. Objectives: To evaluate orthopaedic physicians’ awareness and management of axSpA and factors that might affect appropriate management. Design: An online nationwide survey was conducted among orthopaedic physicians in Germany to assess their axSpA knowledge, diagnostic and therapeutic practices and referral behaviours. Methods: Descriptive statistics were used to summarize participant characteristics and management practices. Machine learning and subgroup analyses identified factors influencing clinical practices. Results: Among 103 orthopaedic physicians (mean age 49.2 ± 11.4 years; 46.6% female), 48.5% practised in both conservative and surgical settings, and 20% held additional qualifications in orthopaedic rheumatology. While 92% regularly treated chronic back pain, only 11.0% estimated the prevalence of inflammatory back pain (IBP) at ⩾5%. Human leucocyte antigen (HLA)-B27 testing was always used by 17.5%, magnetic resonance imaging (MRI) by 14.6% and IBP classification criteria by 22.5%. Nonsteroidal anti-inflammatory drugs were the most common treatment (77%), while 72.1% never used biological disease-modifying antirheumatic drugs. Digital health applications were rarely recommended (14.6%). The majority of physicians (63%) directly referred suspected axSpA cases to rheumatologists, 29% collaborated with rheumatologists and 12% managed cases independently. Referral barriers included long waiting times (66%) and limited appointment availability (33%), while timely appointments (59%) and better referral knowledge (58%) facilitated referrals. Higher self-reported axSpA knowledge was associated with attending ⩾2 rheumatology seminars, conservative orthopaedics settings, regular HLA-B27 testing and familiarity with axSpA MRI results. Conclusion: This study reveals substantial opportunities to improve axSpA awareness, management and referrals among orthopaedic physicians. Targeted education and streamlined referral systems, including easier access to rheumatology appointments, could enable earlier diagnosis and better axSpA management.
- 28 August 2025
- Published by SAGE Publications in Therapeutic Advances in Musculoskeletal Disease
- Vol. 17
Open AccessOrthopaedic physicians’ awareness, diagnostic challenges and referral barriers in axial spondyloarthritis: insights from a nationwide survey in Germany
Background: Axial spondyloarthritis (axSpA) is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, potentially leading to pain, stiffness and disability. Despite diagnostic advances, delays persist. Orthopaedic physicians, often the first specialists consulted for back pain, play a crucial role in early detection and referral to rheumatologists. Objectives: To evaluate orthopaedic physicians’ awareness and management of axSpA and factors that might affect appropriate management. Design: An online nationwide survey was conducted among orthopaedic physicians in Germany to assess their axSpA knowledge, diagnostic and therapeutic practices and referral behaviours. Methods: Descriptive statistics were used to summarize participant characteristics and management practices. Machine learning and subgroup analyses identified factors influencing clinical practices. Results: Among 103 orthopaedic physicians (mean age 49.2 ± 11.4 years; 46.6% female), 48.5% practised in both conservative and surgical settings, and 20% held additional qualifications in orthopaedic rheumatology. While 92% regularly treated chronic back pain, only 11.0% estimated the prevalence of inflammatory back pain (IBP) at ⩾5%. Human leucocyte antigen (HLA)-B27 testing was always used by 17.5%, magnetic resonance imaging (MRI) by 14.6% and IBP classification criteria by 22.5%. Nonsteroidal anti-inflammatory drugs were the most common treatment (77%), while 72.1% never used biological disease-modifying antirheumatic drugs. Digital health applications were rarely recommended (14.6%). The majority of physicians (63%) directly referred suspected axSpA cases to rheumatologists, 29% collaborated with rheumatologists and 12% managed cases independently. Referral barriers included long waiting times (66%) and limited appointment availability (33%), while timely appointments (59%) and better referral knowledge (58%) facilitated referrals. Higher self-reported axSpA knowledge was associated with attending ⩾2 rheumatology seminars, conservative orthopaedics settings, regular HLA-B27 testing and familiarity with axSpA MRI results. Conclusion: This study reveals substantial opportunities to improve axSpA awareness, management and referrals among orthopaedic physicians. Targeted education and streamlined referral systems, including easier access to rheumatology appointments, could enable earlier diagnosis and better axSpA management.
- Open Access
- 21 May 2025
- Published by JMIR Publications Inc. in JMIR Human Factors
- Vol. 12 (1) , e59757
Understanding Dermatologists’ Acceptance of Digital Health Interventions: Cross-Sectional Survey and Cluster Analysis
Background: Digital health interventions (DHIs) have the potential to enhance dermatological care by improving quality, patient empowerment, and efficiency. However, adoption remains limited, particularly in Germany. Objective: This study explores German dermatologists’ attitudes toward DHIs, clustering them by acceptance levels and analyzing differences in sociodemographics and current and future DHI use. Methods: We conducted a cross-sectional survey, randomly inviting 1000 dermatologists in Germany to participate. The questionnaire consisted of Likert scale items rating the acceptability of DHIs from 1 to 5. Items on the current and future use of DHIs were also included. Exploratory factor analysis was used to identify factors and reduce data as input for a 2-step clustering algorithm. Results: The survey with 170 dermatologists (mean age 50.8, SD 10.3 y; 74/167, 55.7% female) identified four factors through the exploratory factor analysis: (1) “Positive Expectancies and Acceptability of DHIs,” (2) “Dermatologists’ Digital Competencies,” (3) “Negative Expectancies and Barriers,” and (4) “Dermatologists’ Perspectives on Patients’ Acceptability and Competencies.” The analysis identified three distinct clusters: (1) Indecisives (n=69)—moderate intentions to use DHIs and moderate negative expectations toward them; (2) Adopters (n=60)—high intentions to use DHIs and high digital competencies; and (3) Rejectors (n=26)—low intentions to use DHIs and low digital competencies. Adopters were significantly younger, more often based in urban centers, and exhibited the highest adoption rates of DHIs compared to the other clusters. Across all clusters, inadequate reimbursement and perceived structural barriers were cited as significant challenges to DHI adoption. Still, only one-third of the Adopters used DHIs including teledermatology or artificial intelligence. Conclusions: Dermatologists in Germany exhibited varied levels of acceptance and readiness for DHIs, with demographic and structural factors influencing adoption. Addressing barriers such as reimbursement and investing in digital literacy could promote wider use, potentially reducing health inequalities by improving access to digital health care.
- 21 May 2025
- Published by JMIR Publications Inc. in JMIR Human Factors
- Vol. 12 (1) , e59757
Open AccessUnderstanding Dermatologists’ Acceptance of Digital Health Interventions: Cross-Sectional Survey and Cluster Analysis
Background: Digital health interventions (DHIs) have the potential to enhance dermatological care by improving quality, patient empowerment, and efficiency. However, adoption remains limited, particularly in Germany. Objective: This study explores German dermatologists’ attitudes toward DHIs, clustering them by acceptance levels and analyzing differences in sociodemographics and current and future DHI use. Methods: We conducted a cross-sectional survey, randomly inviting 1000 dermatologists in Germany to participate. The questionnaire consisted of Likert scale items rating the acceptability of DHIs from 1 to 5. Items on the current and future use of DHIs were also included. Exploratory factor analysis was used to identify factors and reduce data as input for a 2-step clustering algorithm. Results: The survey with 170 dermatologists (mean age 50.8, SD 10.3 y; 74/167, 55.7% female) identified four factors through the exploratory factor analysis: (1) “Positive Expectancies and Acceptability of DHIs,” (2) “Dermatologists’ Digital Competencies,” (3) “Negative Expectancies and Barriers,” and (4) “Dermatologists’ Perspectives on Patients’ Acceptability and Competencies.” The analysis identified three distinct clusters: (1) Indecisives (n=69)—moderate intentions to use DHIs and moderate negative expectations toward them; (2) Adopters (n=60)—high intentions to use DHIs and high digital competencies; and (3) Rejectors (n=26)—low intentions to use DHIs and low digital competencies. Adopters were significantly younger, more often based in urban centers, and exhibited the highest adoption rates of DHIs compared to the other clusters. Across all clusters, inadequate reimbursement and perceived structural barriers were cited as significant challenges to DHI adoption. Still, only one-third of the Adopters used DHIs including teledermatology or artificial intelligence. Conclusions: Dermatologists in Germany exhibited varied levels of acceptance and readiness for DHIs, with demographic and structural factors influencing adoption. Addressing barriers such as reimbursement and investing in digital literacy could promote wider use, potentially reducing health inequalities by improving access to digital health care.
- Open Access
- 19 April 2025
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 39 (10) , 1773-1784
Understanding patient priorities in teledermatology for psoriasis: A discrete choice experiment
Background/Objectives: Despite supporting guidelines and evidence, teledermatology adoption in Germany is low, also possibly due to a lack of services that reflect patients' preferences. This study investigates these preferences in psoriasis care and the influence of sociodemographic, geographic and disease‐related factors.Methods: A discrete choice experiment was conducted. The attributes included the two teledermatology modes (live‐interactive, store‐and‐forward), treating physician, possibility to ask questions and acknowledgment of concerns. The opportunity to prefer the standard of care was given. Participants were randomly assigned to two scenarios: consultation for acute flare‐ups or follow‐up. Conditional logit models were used for analysis.Results: Among 221 patients with psoriasis (mean age: 58.9 years, 39.8% female), a general preference for the standard of care was observed (acute: β = −0.86, p = 0.001; follow‐up: β = −1.24, p = 0.001). Factors that positively influenced preference for teledermatology were medical care provided by the known physician (acute: β = 0.49, p < 0.001; follow‐up: β = 0.51, p < 0.001), the possibility to ask questions (acute: β = 0.35, p < 0.001; follow‐up: β = 0.52, p < 0.001) and a very good acknowledgment of patients' concerns (acute: β = 0.48, p < 0.001; follow‐up: β = 0.50, p < 0.001). Immediate feedback (p < 0.001). No preference for a teledermatology mode was noted in either scenario. In both scenarios, lower privacy concerns and higher technology acceptance positively influenced teledermatology preference. In acute care, current long waiting times, whereas in follow‐up care, current regular blood sampling positively influenced the preference for teledermatology.Conclusions: Patients with psoriasis generally preferred standard‐of‐care over teledermatology. However, certain attributes positively influenced their preference for teledermatology, including consultations with their known treating physician, acknowledgment of patient concerns and prompt consultation during acute flare‐ups. Adapting services to these preferences could increase the use of teledermatology.
- 19 April 2025
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 39 (10) , 1773-1784
Open AccessUnderstanding patient priorities in teledermatology for psoriasis: A discrete choice experiment
Background/Objectives: Despite supporting guidelines and evidence, teledermatology adoption in Germany is low, also possibly due to a lack of services that reflect patients' preferences. This study investigates these preferences in psoriasis care and the influence of sociodemographic, geographic and disease‐related factors.Methods: A discrete choice experiment was conducted. The attributes included the two teledermatology modes (live‐interactive, store‐and‐forward), treating physician, possibility to ask questions and acknowledgment of concerns. The opportunity to prefer the standard of care was given. Participants were randomly assigned to two scenarios: consultation for acute flare‐ups or follow‐up. Conditional logit models were used for analysis.Results: Among 221 patients with psoriasis (mean age: 58.9 years, 39.8% female), a general preference for the standard of care was observed (acute: β = −0.86, p = 0.001; follow‐up: β = −1.24, p = 0.001). Factors that positively influenced preference for teledermatology were medical care provided by the known physician (acute: β = 0.49, p < 0.001; follow‐up: β = 0.51, p < 0.001), the possibility to ask questions (acute: β = 0.35, p < 0.001; follow‐up: β = 0.52, p < 0.001) and a very good acknowledgment of patients' concerns (acute: β = 0.48, p < 0.001; follow‐up: β = 0.50, p < 0.001). Immediate feedback (p < 0.001). No preference for a teledermatology mode was noted in either scenario. In both scenarios, lower privacy concerns and higher technology acceptance positively influenced teledermatology preference. In acute care, current long waiting times, whereas in follow‐up care, current regular blood sampling positively influenced the preference for teledermatology.Conclusions: Patients with psoriasis generally preferred standard‐of‐care over teledermatology. However, certain attributes positively influenced their preference for teledermatology, including consultations with their known treating physician, acknowledgment of patient concerns and prompt consultation during acute flare‐ups. Adapting services to these preferences could increase the use of teledermatology.
- Open Access
- 11 September 2024
- Published by Wiley in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
- Vol. 22 (9) , 1221-1232
Nutzung und Akzeptanz von Digital Health in der Allgemeinbevölkerung und in der Dermatologie in Deutschland – eine repräsentative Umfrage
Zusammenfassung: Hintergrund und Zielsetzung: Die Nutzung und Akzeptanz digitaler Gesundheitsdienste (digital health services, DHS) in der deutschen Bevölkerung und bei Personen mit Hauterkrankungen sind unklar. Beide Aspekte wurden in dieser Studie analysiert.Methodik: Eine repräsentative Stichprobe der deutschen Erwachsenenbevölkerung wurde mit Items zu digitalen Kompetenzen, Einstellungen, zur Nutzung und Akzeptanz von DHS standardisiert befragt. Es wurden bivariate und multivariate Analysen durchgeführt.Ergebnisse: Von den 2101 Teilnehmern gaben 29,9% an, in den letzten 12 Monaten Hautkrankheiten gehabt zu haben. In dieser Gruppe lag die Nutzung und die Akzeptanz von DHS bei 43,6% beziehungsweise 52,3%. Beide Werte sind im Vergleich zu Teilnehmern ohne Hautkrankheiten signifikant höher (29,2%; p < 0,01 und 45,5%; p < 0,01). 18,9% der Teilnehmer mit Hauterkrankung nutzten die digitale Diagnoseunterstützung, aber nur 9,7% wendeten sie für eine Hauterkrankung an (p < 0,01). Bei allen Teilnehmern, mit und ohne Hautkrankheit, waren die am häufigsten genutzten DHS die passive Gesundheitsüberwachung (14,3%) und die Diagnoseunterstützung (11,5%), während die Telemedizin am seltensten genutzt wurde (4,7% Videokonsultation, 2,5% Store‐and‐Forward). Nutzung und Akzeptanz waren assoziiert mit jungem Alter, höherer Bildung, geringeren Datenschutzbedenken, höherer Sicherheit im Umgang mit DHS, einer Hauterkrankung und hohem Schweregrad dieser.Schlussfolgerungen: DHS für Hautkrankheiten werden selten eingesetzt, haben aber ein hohes Potenzial.
- 11 September 2024
- Published by Wiley in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
- Vol. 22 (9) , 1221-1232
Open AccessNutzung und Akzeptanz von Digital Health in der Allgemeinbevölkerung und in der Dermatologie in Deutschland – eine repräsentative Umfrage
Zusammenfassung: Hintergrund und Zielsetzung: Die Nutzung und Akzeptanz digitaler Gesundheitsdienste (digital health services, DHS) in der deutschen Bevölkerung und bei Personen mit Hauterkrankungen sind unklar. Beide Aspekte wurden in dieser Studie analysiert.Methodik: Eine repräsentative Stichprobe der deutschen Erwachsenenbevölkerung wurde mit Items zu digitalen Kompetenzen, Einstellungen, zur Nutzung und Akzeptanz von DHS standardisiert befragt. Es wurden bivariate und multivariate Analysen durchgeführt.Ergebnisse: Von den 2101 Teilnehmern gaben 29,9% an, in den letzten 12 Monaten Hautkrankheiten gehabt zu haben. In dieser Gruppe lag die Nutzung und die Akzeptanz von DHS bei 43,6% beziehungsweise 52,3%. Beide Werte sind im Vergleich zu Teilnehmern ohne Hautkrankheiten signifikant höher (29,2%; p < 0,01 und 45,5%; p < 0,01). 18,9% der Teilnehmer mit Hauterkrankung nutzten die digitale Diagnoseunterstützung, aber nur 9,7% wendeten sie für eine Hauterkrankung an (p < 0,01). Bei allen Teilnehmern, mit und ohne Hautkrankheit, waren die am häufigsten genutzten DHS die passive Gesundheitsüberwachung (14,3%) und die Diagnoseunterstützung (11,5%), während die Telemedizin am seltensten genutzt wurde (4,7% Videokonsultation, 2,5% Store‐and‐Forward). Nutzung und Akzeptanz waren assoziiert mit jungem Alter, höherer Bildung, geringeren Datenschutzbedenken, höherer Sicherheit im Umgang mit DHS, einer Hauterkrankung und hohem Schweregrad dieser.Schlussfolgerungen: DHS für Hautkrankheiten werden selten eingesetzt, haben aber ein hohes Potenzial.
- Open Access
- 3 September 2024
- Published by JMIR Publications Inc. in JMIR Dermatology
- Vol. 7, e57172
Exploring Acceptability, Barriers, and Facilitators for Digital Health in Dermatology: Qualitative Focus Groups With Dermatologists, Nurses, and Patients
Background: Although several digital health interventions (DHIs) have shown promise in the care of skin diseases their uptake in Germany has been limited. To fully understand the reasons for the low uptake, an in-depth analysis of patients’ and health care providers’ barriers and facilitators in dermatology is needed. Objective: The objective of this study was to explore and compare attitudes, acceptability, barriers, and facilitators of patients, dermatologists, and nurses toward DHIs in dermatology. Methods: We conducted 6 web-based focus groups each with patients (n=34), dermatologists (n=30), and nurses (n=30) using a semistructured interview guide with short descriptions of DHIs described in the literature. A content analysis was performed using deductive constructs, following the unified theory of acceptance and use of technology framework, and inductive categories. Results: Patients identified many positive performance expectancies, such as reduced travel times and improvement in follow-up appointments. Dermatologists also stated positive effects (eg, promotion of standardized care), but also negative implications of health care digitalization (eg, increased workload). All stakeholders reported that a DHI should bring additional value to all stakeholders. A lack of digital competence among patients was identified as the major barrier to adoption by all 3 groups. Nurses and dermatologists want apps that are easy to use and easy to implement into their daily routines. Trust in selected institutions, colleagues, and physicians was identified as a facilitator. Patients reported their dependence on the dermatologists’ acceptance. All groups expressed concerns about data privacy risks and dermatologists stated insecurities toward data privacy laws. Conclusions: To ensure successful digitalization in dermatology, apps should be user-friendly, adapted to users’ skill levels, and beneficial for all stakeholders. The incorporation of dermatologists’ perspectives is especially important as their acceptance may impact use among patients and nurses. DHIs should ensure and be transparent about data privacy. The found barriers and facilitators can be used for implementation strategies.
- 3 September 2024
- Published by JMIR Publications Inc. in JMIR Dermatology
- Vol. 7, e57172
Open AccessExploring Acceptability, Barriers, and Facilitators for Digital Health in Dermatology: Qualitative Focus Groups With Dermatologists, Nurses, and Patients
Background: Although several digital health interventions (DHIs) have shown promise in the care of skin diseases their uptake in Germany has been limited. To fully understand the reasons for the low uptake, an in-depth analysis of patients’ and health care providers’ barriers and facilitators in dermatology is needed. Objective: The objective of this study was to explore and compare attitudes, acceptability, barriers, and facilitators of patients, dermatologists, and nurses toward DHIs in dermatology. Methods: We conducted 6 web-based focus groups each with patients (n=34), dermatologists (n=30), and nurses (n=30) using a semistructured interview guide with short descriptions of DHIs described in the literature. A content analysis was performed using deductive constructs, following the unified theory of acceptance and use of technology framework, and inductive categories. Results: Patients identified many positive performance expectancies, such as reduced travel times and improvement in follow-up appointments. Dermatologists also stated positive effects (eg, promotion of standardized care), but also negative implications of health care digitalization (eg, increased workload). All stakeholders reported that a DHI should bring additional value to all stakeholders. A lack of digital competence among patients was identified as the major barrier to adoption by all 3 groups. Nurses and dermatologists want apps that are easy to use and easy to implement into their daily routines. Trust in selected institutions, colleagues, and physicians was identified as a facilitator. Patients reported their dependence on the dermatologists’ acceptance. All groups expressed concerns about data privacy risks and dermatologists stated insecurities toward data privacy laws. Conclusions: To ensure successful digitalization in dermatology, apps should be user-friendly, adapted to users’ skill levels, and beneficial for all stakeholders. The incorporation of dermatologists’ perspectives is especially important as their acceptance may impact use among patients and nurses. DHIs should ensure and be transparent about data privacy. The found barriers and facilitators can be used for implementation strategies.
- Open Access
- 9 August 2024
- Published by JMIR Publications Inc. in JMIR Dermatology
- Vol. 7, e54762
Development, Feasibility, and Acceptability of the Electronic Patient Benefit Index for Psoriasis in Clinical Practice: Mixed Methods Study
Background: Patient-reported outcomes are relevant in clinical practice showing patient benefits, supporting clinicians’ decision-making, and contributing to the delivery of high standards of care. Digital monitoring of patient-reported outcomes is still rare. The Patient Benefit Index (PBI) measures benefits and goals from patients’ views and may be relevant for regular documentation and shared decision-making. Objective: This study aimed to develop electronic versions of the PBI to examine their feasibility and acceptability in clinical practice for patients with psoriasis. Methods: We developed an app and a web version of the existing, valid PBI using focus groups and cognitive debriefings with patients before conducting a quantitative survey on its feasibility and acceptability. Conduction took part in an outpatient dermatology care unit in Germany. Descriptive and subgroup analyses were conducted. Results: A total of 139 patients completed the electronic PBIs (ePBIs) and took part in the survey. The ePBI was understandable (n=129-137, 92.8%-98.6%) and feasible, for example, easy to read (n=135, 97.1%) and simple to handle (n=137, 98.5%). Acceptability was also high, for example, patients can imagine using and discussing the ePBI data in practice (n=91, 65.5%) and documenting it regularly (n=88, 63.3%). They believe it could support treatment decisions (n=118, 84.9%) and improve communication with their physician (n=112, 81.3%). They can imagine filling in electronic questionnaires regularly (n=118, 84.9%), even preferring electronic over paper versions (n=113, 81.2%). Older and less educated people show less feasibility, but the latter expected the relationship with their physician to improve and would be more willing to invest time or effort. Conclusions: The app and web version of the PBI are usable and acceptable for patients offering comprehensive documentation and patient participation in practice. An implementation strategy should consider patients’ needs, barriers, and facilitators but also physicians’ attitudes and requirements from the health care system.
- 9 August 2024
- Published by JMIR Publications Inc. in JMIR Dermatology
- Vol. 7, e54762
Open AccessDevelopment, Feasibility, and Acceptability of the Electronic Patient Benefit Index for Psoriasis in Clinical Practice: Mixed Methods Study
Background: Patient-reported outcomes are relevant in clinical practice showing patient benefits, supporting clinicians’ decision-making, and contributing to the delivery of high standards of care. Digital monitoring of patient-reported outcomes is still rare. The Patient Benefit Index (PBI) measures benefits and goals from patients’ views and may be relevant for regular documentation and shared decision-making. Objective: This study aimed to develop electronic versions of the PBI to examine their feasibility and acceptability in clinical practice for patients with psoriasis. Methods: We developed an app and a web version of the existing, valid PBI using focus groups and cognitive debriefings with patients before conducting a quantitative survey on its feasibility and acceptability. Conduction took part in an outpatient dermatology care unit in Germany. Descriptive and subgroup analyses were conducted. Results: A total of 139 patients completed the electronic PBIs (ePBIs) and took part in the survey. The ePBI was understandable (n=129-137, 92.8%-98.6%) and feasible, for example, easy to read (n=135, 97.1%) and simple to handle (n=137, 98.5%). Acceptability was also high, for example, patients can imagine using and discussing the ePBI data in practice (n=91, 65.5%) and documenting it regularly (n=88, 63.3%). They believe it could support treatment decisions (n=118, 84.9%) and improve communication with their physician (n=112, 81.3%). They can imagine filling in electronic questionnaires regularly (n=118, 84.9%), even preferring electronic over paper versions (n=113, 81.2%). Older and less educated people show less feasibility, but the latter expected the relationship with their physician to improve and would be more willing to invest time or effort. Conclusions: The app and web version of the PBI are usable and acceptable for patients offering comprehensive documentation and patient participation in practice. An implementation strategy should consider patients’ needs, barriers, and facilitators but also physicians’ attitudes and requirements from the health care system.